New vaccine aims to shield infants from deadly pneumonia

NCT ID NCT07017777

Ongoing ⭐️ VACCINE ⭐️ Sponsor: CanSino Biologics Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 06, 2026 · Updated 2 times

Summary

This study tests a new vaccine to protect babies against pneumococcal infections, which can cause pneumonia and meningitis. About 600 healthy infants in Thailand will receive either the new or a standard vaccine at 2, 4, and 12-15 months old. Researchers will check how well the vaccine works and if it is safe by tracking side effects and immune responses.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BACTERIAL INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bacterial infectious disease streptococcal infection pneumococcal infection prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BACTERIAL INFECTIONS PNEUMOCOCCAL INFECTIONS STREPTOCOCCAL INFECTIONS

Contacts and locations

Locations

Faculty of Medicine Siriraj Hospital, Mahidol University

Bangkok, Thailand
King Chulalongkorn Memorial Hospital

Bangkok, Thailand
Phramongkutklao Hospital

Bangkok, Thailand

More trials for these conditions

Other studies related to the condition(s) this trial covers.